71 related articles for article (PubMed ID: 8818577)
21.
Eckernäs E; Macan-Schönleben A; Andresen-Bergström M; Birgersson S; Hoffmann KJ; Ashton M
Xenobiotica; 2023 Dec; 53(8-9):515-522. PubMed ID: 37916667
[No Abstract] [Full Text] [Related]
22. Metabolic Activation of Atomoxetine Mediated by Cytochrome P450 2D6.
You Y; Wang X; Ma K; Li J; Peng Y; Zheng J
Chem Res Toxicol; 2021 Sep; 34(9):2135-2144. PubMed ID: 34431675
[TBL] [Abstract][Full Text] [Related]
23. The Utility of Mixed Effects Models in the Evaluation of Complex Genomic Traits In Vitro.
Alade N; Nath A; Isoherranen N; Thummel KE
Drug Metab Dispos; 2023 Nov; 51(11):1455-1462. PubMed ID: 37562955
[TBL] [Abstract][Full Text] [Related]
24. Baclofen and the risk of fall and fracture in older adults: A real-world cohort study.
Hwang YJ; Chang AR; Brotman DJ; Inker LA; Grams ME; Shin JI
J Am Geriatr Soc; 2024 Jan; 72(1):91-101. PubMed ID: 37933734
[TBL] [Abstract][Full Text] [Related]
25. The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions.
Villemure S; Trenaman SC; Goralski KB
Expert Opin Drug Metab Toxicol; 2023; 19(6):329-332. PubMed ID: 37345482
[No Abstract] [Full Text] [Related]
26. Gender difference in the pharmacokinetics and metabolism of VX-548 in rats.
Yu G; Zhou X
Biopharm Drug Dispos; 2024 Apr; 45(2):107-114. PubMed ID: 38573807
[TBL] [Abstract][Full Text] [Related]
27. On the Tip of Our Tongue: Sublingual Cyclobenzaprine and Fibromyalgia.
Lall M; Jackson CD
South Med J; 2024 Mar; 117(3):172-173. PubMed ID: 38428940
[No Abstract] [Full Text] [Related]
28. Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations.
Zhu LL; Wang YH; Zhou Q
J Pain Res; 2024; 17():1257-1271. PubMed ID: 38529017
[TBL] [Abstract][Full Text] [Related]
29. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.
Majid H; Puzik A; Maier T; Merk R; Bartel A; Mueller HC; Burckhardt BB
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575485
[TBL] [Abstract][Full Text] [Related]
30. Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study.
Chaugai S; Dickson AL; Shuey MM; Feng Q; Barker KA; Wei WQ; Luther JM; Stein CM; Chung CP
Clin Pharmacol Ther; 2019 Mar; 105(3):703-709. PubMed ID: 30223305
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets.
Brioschi TM; Schramm SG; Kano EK; Koono EE; Ching TH; Serra CH; Porta V
Biomed Res Int; 2013; 2013():281392. PubMed ID: 24151591
[TBL] [Abstract][Full Text] [Related]
32. Monotherapy or combination therapy for fibromyalgia treatment?
Calandre EP; Rico-Villademoros F; Rodríguez-López CM
Curr Rheumatol Rep; 2012 Dec; 14(6):568-75. PubMed ID: 22806139
[TBL] [Abstract][Full Text] [Related]
33. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.
Mestres J; Seifert SA; Oprea TI
Clin Pharmacol Ther; 2011 Nov; 90(5):662-5. PubMed ID: 21975349
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.
Brown CS; Farmer RG; Soberman JE; Eichner SF
Clin Pharmacokinet; 2004; 43(1):33-56. PubMed ID: 14715050
[TBL] [Abstract][Full Text] [Related]
35. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
36. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
37. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.
Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
